Two top executives at Axsome Therapeutics, Inc. (AXSM) sold a significant amount of company stock on June 9, 2026. Chief Executive Officer Herriot Tabuteau sold 49,670 shares for approximately $11.97 million, while Chief Financial Officer Nick Pizzie sold 33,000 shares for approximately $7.92 million. The total value of these transactions amounts to nearly $20 million.
These sales come as part of a broader trend of insider selling activity at Axsome Therapeutics in recent weeks. While individual insider sales can be attributed to various personal financial decisions, such as diversification or tax planning, coordinated or substantial selling by multiple executives can sometimes draw investor attention.
Axsome Therapeutics is a biopharmaceutical company focused on therapies for central nervous system disorders. The company's stock performance and strategic developments are closely watched by market participants.